medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2021; 19 (2)

Aspergillus proliferans Onychomycosis Forming Fungal Masses

Lemini LA, Tapia AGB, Méndez TLJ, Herrera RBS, Hernández HF
Full text How to cite this article

Language: English
References: 28
Page: 174-179
PDF size: 219.03 Kb.


Key words:

dermatophytoma, onychomycosis, Aspergillus sp., dermatophytosis, Aspergillus proliferans.

ABSTRACT

Onychomycosis are nail infections that can be caused by dermatophytes, yeasts or molds, representing the most frequent superficial mycosis worldwide. Dermatophytoma is a variety of onychomycosis characterized by forming fungal masses and it is caused by dermatophytes, particularly Trichophyton rubrum. However, other non-dermatophyte filamentous fungi, including Aspergillus sp., have been reported. This clinical variety has been associated to failure to conventional antifungal treatment.
The aim of this work is to present a clinical case of immunocompromised patient due to transplantation protocol, with diagnosis of onychomycosis caused by Aspergillus proliferans and propose the term onychofungoma to refer to onychomycosis caused by non-dermatophyte filamentous fungi forming fungal masses.
Several direct examinations of toenail scales, culture on Sabouraud dextrose agar with and without cycloheximide/chloramphenicol and molecular identification by pcr-sequencing using two molecular markers were performed.
The nail microscopic examination showed multiple clusters of light brown hyphae. In culture numerous colonies of a filamentous fungus, microscopically compatible with Aspergillus sp. developed. The molecular identification and the phenotypic study determined Aspergillus proliferans as the etiological agent of onychomycosis.
Onychomycosis whose microscopic study shows fungal masses must be timely attended to avoid patient life-threatening complications, especially when there are risk factors as immunosuppression in the present case. We propose the term onychofungoma (onycho = referent to nail; fungoma = fungal mass) to refer to onychomycosis cases showing fungal masses formed by non-dermatophytic filamentous fungi.


REFERENCES

  1. De Berker D, Clinical practice. Fungal nail disease, N Engl J Med 2009; 360:2108-16.

  2. Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R et al., A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns, J Am Acad Dermatol 2000; 43:641-8.

  3. López-Martínez R, Manzano-Gayosso P, Hernández-Hernández F, Bazán-Mora E y Méndez-Tovar LJ, Dynamics of dermatophytosis frequency in Mexico: an analysis of 2 084 cases, Med Mycol 2010; 48:476-9.

  4. Motamedi M, Ghasemi Z, Shidfar MR, Ghasemi Z, Shidfar MR, Hosseinpour L et al., Growing incidence of non-dermatophyte onychomycosis in Tehran, Iran, Jundishapur J Microbiol 2016; 9:e40543.

  5. Arrua JM, Rodrigues LA, Pereira FO y Lima EO, Prevalence of Candida tropicalis and Candida krusei in onychomycosis in João Pessoa, Paraiba, Brazil from 1999 to 2010, An Acad Bras Cienc 2015; 87:1819-22.

  6. Gasser J, Pagani E, Vittadello F, Nobile C, Zampieri P y Eisendle K, Frequency, type and treatment of fungal pathogens in toenail onychomycosis in the central Alpine region of South Tyrol, northern Italy: a 10-year retrospective study from 2004 to 2013, Mycoses 2016; 59:760-4.

  7. Roberts D y Evans E, Subungual dermatophytoma complicating dermatophyte onychomycosis, Br J Dermatol 1998; 138:189-90.

  8. Bennett D y Rubin AI, Dermatophytoma: a clinicopathologic entity important for dermatologists and dermatopathologists to identify, Int J Dermatol 2013; 52:1285-7.

  9. Burkhart CN, Burkhart CG y Gupta AK, Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm, J Am Acad Dermatol 2002; 47:629-31.

  10. Martínez E, Alas R, Escalante K, Miller K y Arenas R, Dermatofitoma subungueal. Estudio epidemiológico de 100 casos, Rev Chilena Dermatol 2010; 26:22-4.

  11. Sato T, Horikawa H y Yamazaki K, Mold mite infestation in toenail dermatophytoma with pustular psoriasis, J Dtsch Dermatol Ges 2020; 18:251-2.

  12. Wang C, Cantrell W, Canavan T y Elewski B, Successful treatment of dermatophytomas in 19 patients using efinaconazole 10% solution, Skin Appendage Disord 2019; 5:304-8.

  13. Moreno G y Arenas R, Dermatofitoma extraungueal, Rev Iberoam Micol 2009; 26:165-6.

  14. Martínez E, Pérez MF, Alas R, Rivas E, Escalante K, Valencia C et al., Dermatofitoma extraungueal. Comunicación de 15 casos, Dermatol Rev Mex 2010; 54:10-3.

  15. Martínez E, Ameen M, Tejada D y Arenas R, Microsporum spp. onychomycosis: disease presentation, risk factors and treatment responses in an urban population, Braz J Infect Dis 2014; 18:181-6.

  16. Gupta AK, Baran R y Summerbell R, Onychomycosis: strategies to improve efficacy and reduce recurrence, J Eur Acad Dermatol Venereol 2002; 16:579-86.

  17. Sigurgeirsson B, Prognostic factors for cure following treatment of onychomycosis, J Eur Acad Dermatol Venereol 2010; 24: 679-84.

  18. Luo G y Mitchell TG, Rapid identification of pathogenic fungi directly from cultures by using multiplex pcr, J Clin Microbiol 2002; 40:2860-5.

  19. Glass NL y Donaldson GC, Development of primer sets designed for use with the pcr to amplify conserved genes from filamentous ascomycetes, Appl Environ Microbiol 1995; 61:1323-30.

  20. Gómez de Membrillera JL, Clave determinativa de las especies del género Aspergillus, Ann Univ Murcia 1950; 3:25-85.

  21. Hubka V, Kubatova A, Mallatova N, Sedlacek P, Melichar J, Skorepova M et al., Rare and new etiological agents revealed among 178 clinical Aspergillus strains obtained from Czech patients and characterized by molecular sequencing, Med Micol 2012; 50:601-10.

  22. Aly R, Winter T, Hall S y Vlahovic T, Topical tavaborole in the treatment of onychomycosis complicated by dermatophytoma: a posthoc assessment of phase ii subjects, J Drugs Dermatol 2018; 17:347-54.

  23. Verne SH, Chen L, Shah V, Nouri K y Tosti A, Optical coherence tomography features of dermatophytoma, jama Dermatol 2018; 154:225-7.

  24. Summerbell RC, Cooper E, Bunn U, Jamieson F y Gupta AK, Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes, Med Mycol 2005; 43:39-59.

  25. Chabasse D y Pihet M, Les onychomycoses à moisissures, J Mycol Med 2014; 24:261-8.

  26. Hubka V, Kolarˇík M, Kubátová A y Peterson SW, Taxonomic revision of Eurotium and transfer of species to Aspergillus, Mycologia 2013; 105:912-37.

  27. Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N y Baran R, Taskforce on onychomycosis education. Treatment options-development of consensus guidelines, J Eur Acad Dermatol Venereol 2005; 19 Suppl 1:25-33.

  28. Mouhamadou B, Sage L, Périgon S, Séguin V, Bouchart V, Legendre P et al., Molecular screening of xerophilic Aspergillus strains producing mycophenolic acid, Fungal Biol 2017; 121:103-11.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2021;19